Wedbush Equities Analysts Lower Earnings Estimates for NBIX
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) – Equities research analysts at Wedbush dropped their Q1 2025 earnings estimates for Neurocrine Biosciences in a report issued on Wednesday, April 16th. Wedbush analyst L. Chico now anticipates that the company will earn $1.10 per share for the quarter, down from their prior estimate of $1.33. Wedbush […]
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) – Equities research analysts at Wedbush dropped their Q1 2025 earnings estimates for Neurocrine Biosciences in a report issued on Wednesday, April 16th. Wedbush analyst L. Chico now anticipates that the company will earn $1.10 per share for the quarter, down from their prior estimate of $1.33. Wedbush […]
